InvestorsHub Logo
Followers 800
Posts 50862
Boards Moderated 2
Alias Born 12/12/2004

Re: crudeoil24 post# 23

Monday, 02/03/2020 8:29:31 AM

Monday, February 03, 2020 8:29:31 AM

Post# of 31
Aimmune Therapeutics, Inc. (NASDAQ:AIMT) shares increased by 15.5% to $35.87 during Monday's pre-market session. The most recent rating by Cantor Fitzgerald, on February 03, is at Overweight, with a price target of $64.00.

New York Yankees and Duke Basketball